Cancer Immunology
Cancer immunology has been an area of investigation since the 1960s but it is within the last decade that we have seen its promise start to come to fruition. Indeed, tumor-induced immune-suppression is now recognized as a key factor in oncogenic progression and immune-based therapeutics are becoming first or second-line options in an increasing array of malignancies.
We are very proud that Oncogene has become an important voice in the cancer immunology conversation and we are pleased to present our collection of recently published papers in the field. These include both cutting edge original research articles as well as timely review papers. They add new targets and an understanding of mechanisms to this incredibly exciting area of translational cancer therapeutics. We hope you enjoy this selection.
